注冊 | 登錄讀書好,好讀書,讀好書!
讀書網(wǎng)-DuShu.com
當(dāng)前位置: 首頁出版圖書科學(xué)技術(shù)自然科學(xué)生物科學(xué)合成生物學(xué):倫理風(fēng)險與治理對策(英文版)

合成生物學(xué):倫理風(fēng)險與治理對策(英文版)

合成生物學(xué):倫理風(fēng)險與治理對策(英文版)

定 價:¥99.00

作 者: 雷瑞鵬
出版社: 華中科技大學(xué)出版社
叢編項:
標(biāo) 簽: 暫缺

ISBN: 9787577212371 出版時間: 2025-02-01 包裝: 平裝
開本: 32開 頁數(shù): 字?jǐn)?shù):  

內(nèi)容簡介

  合成生物學(xué)作為認(rèn)識生命的“鑰匙”、改變未來的顛覆性技術(shù),打開了從非生命物質(zhì)向生命物質(zhì)轉(zhuǎn)化的大門,實現(xiàn)生命體系的理性設(shè)計與編輯,為生命科學(xué)研究提供了新范式,促進(jìn)生物技術(shù)迭代發(fā)展,成為未來生物產(chǎn)業(yè)發(fā)展的驅(qū)動力。經(jīng)過20余年的發(fā)展,合成生物學(xué)領(lǐng)域已取得系列突破,創(chuàng)新應(yīng)用逐步實現(xiàn)。近年合成生物學(xué)的快速發(fā)展也帶來了許多倫科學(xué)、倫理和治理上的問題和挑戰(zhàn)。在科學(xué)的維度,合成生物學(xué)從生物技術(shù)、生物工程學(xué)科逐步過渡到現(xiàn)在的形態(tài),其科學(xué)特征以及學(xué)科體系的基礎(chǔ)仍需要進(jìn)一步說明和澄清。在倫理和治理上,合成生物學(xué)的發(fā)展和應(yīng)用引起許多決策者和利益相關(guān)方的關(guān)切,如是否應(yīng)該合成生命系統(tǒng)、合成生物學(xué)是否會帶來分配的不公正、是否有適當(dāng)?shù)闹贫葋砉芾磉@些技術(shù),以及公眾如何、何時參與這些決策。《合成生物學(xué):科學(xué)、倫理與治理》從合成生物學(xué)的學(xué)科特征及其發(fā)展態(tài)勢、合成生物學(xué)中的重要倫理問題及治理方案和合成生物學(xué)的倫理治理框架等方面進(jìn)行了闡述。

作者簡介

  電子科技大學(xué)馬克思主義學(xué)院教授/博導(dǎo),科技倫理治理研究中心主任。2019年5月9日在國際*科學(xué)期刊Nature發(fā)表國內(nèi)人文學(xué)科領(lǐng)域第一篇研究論文“Reboot Ethics Governance in China”(《重建中國的倫理治理》),在國內(nèi)首次提出“科技倫理治理”和“倫理先行”概念,并系統(tǒng)闡述科技倫理治理基本原則,相關(guān)概念和原則已被系列中央文件和兩辦《關(guān)于加強科技倫理治理意見》采納。生命倫理學(xué)創(chuàng)始研究機構(gòu)Hastings中心Fellow,中國自然辨證法研究會理事,中國倫理學(xué)會常務(wù)理事。

圖書目錄

ContentsPART ⅠEthical Debates on Synthetic Biology1An Analysis of the “Playing God” Argument against Synthetic Biology1.1Introduction1.2The Origin of “Playing God” Argument1.3The Interpretation of the Expression of Playing God1.4The Debate on Whether Synthetic Biology “Plays God”1.5Deficiencies of “Playing God” as an Argument1.6References2Some Remarks on the Argument Appealing to Nature against Synthetic Biology2.1Introduction2.2The Argument Appealing to Nature against Synthetic Biology and an Analysis of Its Deficiencies2.3Ambiguity of the Concept Nature2.4Problems in the Morally Significant Line between the Natural and the Non/Unnatural2.5Allegations to Synthetic Biology Stemming from Argument Appealing to Nature2.6Conclusion2.7References3On the Biocentrist Argument against Synthetic Biology3.1Introduction3.2Biocentrism and Its Advocates: A Critique of Synthetic Biology3.3Argument Appealing to Natural Evolutionary History3.4Argument Appealing to Teleological Organization3.5Argument Appealing to the Good of Own or Interests3.6References4Research on Responsibility Ethics of DNA Synthesis Technology4.1Introduction4.2Ethics of Responsibility of Hans Jonas4.3The Necessity of Applying Ethics of Responsibility in DNA Synthesis Techniques4.4Application of Ethics of Responsibility in the Practice of DNA Synthesis Technology4.5Suggestions for Applying Ethics of Responsibility in the Practice of DNA Synthesis Technology4.6Conclusion4.7References5Analysis of Ethics Dumping and Proposed Solutions in the Field of Biomedical Research in China5.1Introduction5.2The Definition of Ethics Dumping5.3Typical Cases of Ethics Dumping in Biomedical Research in China5.4Analysis of the Causes of Ethics Dumping in Biomedical Research in China5.5Policy Recommendations5.6ReferencesPART ⅡRisk Analysis in Synthetic Biology6Safety Risks and Ethical Governance of Biomedical Applications of Synthetic Biology6.1Introduction6.2The Biomedical Applications of Synthetic Biology6.3An Analysis of the Safety Risks of the Application of Synthetic Biology within Biomedicine6.4Ethical Considerations in the Application of Synthetic Biology within the Biomedical Field6.5Recommendations for Ethical Governance of Biomedical Applications of Synthetic Biology6.6Conclusion6.7References7Risks and Governance Recommendation for Synthetic Virus Technology from an Ethical Perspective7.1Introduction7.2Synthetic Virus Technology and Kinds of Risks7.3Challenges Faced by Existing Risk Governance Strategies7.4Governance Recommendations for Synthetic Virus Technology7.5Conclusion7.6References8Ethical Perspective on the Risk Assessment and Prospective Governance of Synthetic Biofuels8.1Introduction8.2Risk Assessment and Ethical Issues of Synthetic Biofuels8.3Prospective Governance of Synthetic Biofuels from an Ethical Perspective8.4Conclusion8.5References9Challenges and Principled Responses to Privacy Protection from Biometric Technology in China9.1Introduction9.2The Definition of Biometric Technology and Biometric Characteristics9.3The Challenges of Biometric Technology for Privacy Protection9.4Principled Responses to Privacy Protection from Biometric Technology9.5Conclusion9.6ReferencesPART ⅢGovernance Countermeasures in Synthetic Biology10Ethical Framework on Risk Governance of Synthetic Biology10.1Introduction10.2The Relationship between Environmental Risk and Synthetic Biology10.3Methods for Environmental Risk Assessment of Synthetic Biology10.4Ethical Principles in Environmental Risk Governance10.5Conclusion10.6References11Establishing a Management Framework for Biosafety Risk Assessments of Synthetic Biology11.1Introduction11.2Synthetic Biology Enabling Technology11.3Biosafety Risk Assessments of Synthetic Biology11.4Framework for Biosafety Risk Assessments11.5Discussion11.6Summary11.7References12Risks and Countermeasures of LaboratoryAcquired Infection Based on Pathogen Transmission Routes12.1Introduction12.2LAI Risk Analysis Based on Transmission Routes12.3Response to LAIs with Different Transmission Routes12.4Comprehensive Strategy12.5Conclusion12.6References13Regulation and Management of the Biosecurity for Synthetic Biology13.1Introduction13.2Biosecurity Risks of Synthetic Biology13.3Situation of the Regulation and Management of Biosecurity for Synthetic Biology in the International Community13.4Situation of the Regulation and Management of Biosecurity for Synthetic Biology in China13.5Suggestions on the Regulation and Management of Biosecurity for Synthetic Biology in China13.6Conclusion13.7References14Can Synthetic Biological Products Be Applied to the Cartagena Protocol on Biosafety?14.1Introduction14.2Progress in the Negotiation of Synthetic Biology under the Framework of the CBD14.3Application of Synthetic Biological Products under the Rules of the Biosafety Protocol14.4Conclusion14.5References15A Leap of Faith: Building the Trust in Human Biobanks15.1Introduction15.2Theoretical Foundations of Public Trust in HBs: A Leap of Faith15.3Is There a Universal Formula for the Construction of Public Trust in HBs?15.4Schemes for the Establishment and Reinforcement of Public Trust in HBs15.5Conclusion15.6References

本目錄推薦

掃描二維碼
Copyright ? 讀書網(wǎng) www.talentonion.com 2005-2020, All Rights Reserved.
鄂ICP備15019699號 鄂公網(wǎng)安備 42010302001612號